1. Incidence of drug-drug interactions of QT-prolonging drugs in an onco-hematological outpatient. (3rd October 2022) Authors: Fort, E; Otero, S; Moliner, P; Bleda, C; Prats, J; Nadal, E; Palmero, R; Jimenez, L; Piulats, J M; Rey, M; Fontanals, S Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LBA65IMpower131: Progression-free survival (PFS) and overall survival (OS) analysis of a randomised phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel in 1L advanced squamous NSCLC. (23rd October 2018) Authors: Socinski, M A; Rittmeyer, A; Shapovalov, D; Orlandi, F; McCleod, M; Soo, R A; Palmero, R; Kozuki, T; Migliorino, M R; Koynov, K D; Berard, H; Hughes, B G M; Yu, W; Graupner, V; Sun, S W; Kowanetz, M; Hoang, T; Lin, W; Jotte, R M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P05.21 T1-flair to T1-gadolinium MRI ratio as a predictive value of treatment response in non-small-cell lung cancer (NSCLC) patients affected by multiple brain metastases. (19th September 2018) Authors: Alemany, M; Domènech, M; Vilariño, N; Jové, M; Brao, I; Arellano, M; Lucas, A; Navarro, A; Palmero, R; Simó, M; Velasco, R; Nadal, E; Bruna, J Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P05.21 T1-flair to T1-gadolinium MRI ratio as a predictive value of treatment response in non-small-cell lung cancer (NSCLC) patients affected by multiple brain metastases. (19th September 2018) Authors: Alemany, M; Domènech, M; Vilariño, N; Jové, M; Brao, I; Arellano, M; Lucas, A; Navarro, A; Palmero, R; Simó, M; Velasco, R; Nadal, E; Bruna, J Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P16.01.A Factors predicting cognitive impairment after intrathecal methotrexate treatment in patients with non-small cell lung cancer and leptomeningeal disease. (5th September 2022) Authors: Vilariño, N; Esparragosa, I; Marín, J; Alemany, M; Velasco, R; Jové, M; Brenes, J; Palmero, R; Brao, I; Arellano, M; Sala, R; Bruna, J; Nadal, E; Simó, M Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer. (14th May 2018) Authors: Gerber, D E; Horn, L; Boyer, M; Sanborn, R; Natale, R; Palmero, R; Bidoli, P; Bondarenko, I; Germonpre, P; Ghizdavescu, D; Kotsakis, A; Lena, H; Losonczy, G; Park, K; Su, W -C; Tang, M; Lai, J; Kallinteris, N L; Shan, J S; Reck, M Journal: Annals of oncology Issue: Volume 29:Number 7(2018) Page Start: 1548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗